Dual-cytokine-armed oncolytic HSV for enhanced tumor immunotherapy. [PDF]
Dhital R, Pereira MSF.
europepmc +1 more source
Multimodal Key Anti-Oncolytic Therapeutics Are Effective In Cancer Treatment? [PDF]
Ye L +5 more
europepmc +1 more source
Basic stochastic model for tumor virotherapy
Tuan Anh Phan, Jianjun Paul Tian
openalex +1 more source
Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma. [PDF]
Luo Y, Hu Z, Du G, Xin W, Wang M.
europepmc +1 more source
Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. [PDF]
Labé C +15 more
europepmc +1 more source
Oncolytic virotherapy and tumor microenvironment modulation. [PDF]
Rivera-Orellana S +11 more
europepmc +1 more source
Future clinical potential of oncolytic virotherapy for pediatric CNS tumors [PDF]
Cockle, JV, Melcher, A, Picton, SV
core +1 more source
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity. [PDF]
Hayes AJ +18 more
europepmc +1 more source
<i>Vaccinia Virus</i> Converts Microglia into Potent Oncolytic Agent for Glioblastoma and Neuroblastoma. [PDF]
Ekrami E +3 more
europepmc +1 more source

